Historical Stock Price
BLUE historical stock prices picture
bluebird bio (BLUE) has the following price history information. Looking back at BLUE historical stock prices for the last five trading days, on April 12, 2024, BLUE opened at $1.15, traded as high as $1.19 and as low as $1.07, and closed at $1.10. Trading volume was a total of 6.45M shares. On April 15, 2024, BLUE opened at $1.11, traded as high as $1.12 and as low as $1.01, and closed at $1.03. Trading volume was a total of 7.85M shares. On April 16, 2024, BLUE opened at $1.04, traded as high as $1.07 and as low as $0.98, and closed at $0.99. Trading volume was a total of 5.92M shares. On April 17, 2024, BLUE opened at $0.96, traded as high as $1.03 and as low as $0.95, and closed at $0.96. Trading volume was a total of 8.69M shares. On April 18, 2024, BLUE opened at $0.97, traded as high as $1.01 and as low as $0.92, and closed at $0.95. Trading volume was a total of 6.53M shares.

BLUE Historical Stock Prices By Date:

BLUE historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into bluebird bio shares, starting with a $10,000 purchase of BLUE, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/18/2024
Start price/share: $13.87
End price/share: $0.95
Dividends collected/share: $0.00
Total return: -93.15%
Average Annual Total Return: -23.52%
Starting investment: $10,000.00
Ending investment: $685.17
Years: 10.00
Date Open High Low Close Volume
04/12/2024 $1.15 $1.19 $1.07 $1.10 6.45M
04/15/2024 $1.11 $1.12 $1.01 $1.03 7.85M
04/16/2024 $1.04 $1.07 $0.98 $0.99 5.92M
04/17/2024 $0.96 $1.03 $0.95 $0.96 8.69M
04/18/2024 $0.97 $1.01 $0.92 $0.95 6.53M
bluebird bio is a biotechnology company focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector gene addition platform. Co. has two gene therapies: ZYNTEGLO® (betibeglogene autotemcel, also known as beti-cel) and SKYSONA® (elivaldogene autotemcel, also known as eli-cel). ZYNTEGLO is for the treatment of adult and pediatric patients with B-thalassemia who require regular red blood cell transfusions. SKYSONA is for slowing the progression of neurologic dysfunction in boys four to 17 years of age with early active cerebral adrenoleukodystrophy.
Date Close
04/12/2024$1.10
04/15/2024$1.03
04/16/2024$0.99
04/17/2024$0.96
04/18/2024$0.95
BLUE is categorized under the Healthcare sector; below are some other companies in the same sector:

BMRA Historical Stock Prices
BMRN Historical Stock Prices
BMY Historical Stock Prices
BNC Historical Stock Prices
BOLD Historical Stock Prices
BONE Historical Stock Prices
BOT Historical Stock Prices
BOTA Historical Stock Prices
BPAX Historical Stock Prices
BPMC Historical Stock Prices

Also explore: BLUE shares outstanding history

Email EnvelopeFree BLUE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


BLUE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.